Pharmaceutical compositions for managing scalp conditions
OwnerHoward Muradinventor
Life of this patent
Estimating the term…
Loading patent…
OwnerHoward Muradinventor
Estimating the term…
This application relates to a pharmaceutical composition for the prevention, treatment, and management of scalp conditions, such as dandruff, seborrheic dermatitis, psoriasis, folliculitis, and hair thinning including a therapeutically effective amount of an acidic component of a hydroxyacid or tannic acid, or a pharmaceutically acceptable salt thereof. A preferred anti-dandruff composition and method of managing dandruff includes a therapeutically effective amount of the acid component, a vitamin A component, and an anti-growth agent. A preferred anti-hair thinning composition and method of managing thinning hair includes a therapeutically effective amount of the acidic component, a niacin component present in an amount sufficient to locally increase blood circulation, and a 5-α reductase inhibitor. The invention also relates to a method of treating chemically processed air by administering to a patient an amount of an acidic component of a hydroxy acid or tannic acid, or a pharmaceutically acceptable salt thereof, in an amount sufficient to essentially close the cuticle and inhibit modification of the chemically processed hair.
An anti-hair thinning pharmaceutical composition for administration to a scalp consisting essentially of:
An anti-hair thinning pharmaceutical kit consisting essentially of a topical component that consists essentially of an acidic component in an amount sufficient to exfoliate at least a portion of the scalp, and a niacin component present in an amount sufficient to locally increase blood circulation, and an oral component that consists essentially of a 5-α reductase inhibitor in an amount sufficient to inhibit conversion of testosterone to dihydrotestosterone.
Dependencies are inferred from the claim text.